Lumbosacral Radicular Pain Management Global Market Report 2025
상품코드:1769645
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
요천추 신경근 통증 관리 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 예상 성장은 최소 침습 수술 기술의 혁신, 생물학적 치료법의 채택 증가, 개인 맞춤형 통증 관리에 대한 강조 증가, 외래 통증 클리닉에 대한 수요 증가, 디지털 건강 및 원격 의료의 통증 관리 관행에 대한 통합에 기인할 수 있습니다. 이 기간 동안 예상되는 주요 동향으로는 최소 침습 척추 수술의 발전, 신경 자극 장치의 발전, 혈소판이 풍부한 혈장 등 생물학적 치료법의 사용, AI 기반 진단 및 개인 맞춤형 치료 전략의 적용, 새로운 비오피오이드 진통제의 개발 등이 있습니다.
요통 장애의 유병률이 증가함에 따라 앞으로 몇 년 동안 요천추 신경통 관리 시장이 성장할 것으로 예상됩니다. 허리 통증 장애는 척추, 근육, 또는 허리의 신경에 영향을 미치는 다양한 질환을 포함하며, 불편감이나 통증을 유발합니다. 이 증가세는 주로 허리 근육을 약화시키는 앉은 자세 위주의 생활 방식이 자세 불량과 만성 통증을 초래하기 때문입니다. 요천추 신경근 통증 관리는 허리 하부의 신경근 자극을 완화하여 통증과 염증을 줄이고, 운동 범위를 회복하며, 전반적인 삶의 질을 향상시키는 데 초점을 맞춥니다. 예를 들어(2024년) 6월 호주 보건 복지 연구소(정부 기관)는 2022년 척추 문제로 인한 입원 사례 중 절반 이상(52%)이 허리나 척추 통증 때문이었으며, 이 중 하부 허리 통증이 27%로 가장 높은 비율을 차지했고, 목 통증이 6.2%, 신경근 통증이 6.0%를 차지했다고 보고했습니다. 또한, 2023년에는 허리 문제가 전체 건강 부담의 3위 원인이 되었으며, 전체 영향의 4.3%를 차지했습니다. 그 결과, 요통 질환의 유병률 증가는 요천추 신경근 통증 관리 시장의 확장을 촉진하는 주요 요인이 되고 있습니다.
요천추 신경근 통증 관리 시장의 선도 기업들은 오피오이드가 아닌 장기적인 통증 완화를 위한 치료법을 개발하기 위해, 임상 시험 중인 경구용 NaV1.8 통증 신호 억제제 등 첨단 치료법 개발에 주력하고 있습니다. 이 임상 시험용 의약품은 감각 신경을 통해 통증 신호를 전달하는 중요한 요소인 NaV1.8 나트륨 채널을 표적으로 합니다. 예를 들어(2024년) 12월 미국 바이오기술 기업 Vertex Pharmaceuticals는 요천추 신경근 통증(LSR) 치료를 위한 suzetrigine의 Phase 2 임상 시험 결과를 발표했습니다. 이 시험은 주요 평가 지표를 달성했으며, suzetrigine을 투여받은 환자의 통증이 기저치 대비 통계적으로 유의미하고 임상적으로 의미 있는 감소세를 보였습니다. 이 의약품은 전반적으로 내약성이 좋고, 심각한 부작용은 보고되지 않았습니다. Vertex는 약물의 효능을 더 잘 평가하기 위해 향후 3상 임상 시험에서 이 연구에서 관찰된 높은 위약 반응에 대해 해결할 계획입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 요천추 신경근 통증 관리 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 요천추 신경근 통증 관리 시장 : 성장률 분석
세계의 요천추 신경근 통증 관리 시장 실적 : 규모와 성장(2019-2024년)
세계의 요천추 신경근 통증 관리 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 요천추 신경근 통증 관리 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 요천추 신경근 통증 관리 시장 : 의약품별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비스테로이드성 항염증제
오피오이드
항우울제
항경련제
스테로이드
세계의 요천추 신경근 통증 관리 시장 : 물리치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
수기요법
운동요법
전기요법
온열요법
하이드로테라피
세계의 요천추 신경근 통증 관리 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
국소
세계의 요천추 신경근 통증 관리 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 요천추 신경근 통증 관리 시장 : 비스테로이드성 항염증제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
이부프로펜
나프록센
디클로페낙
셀레콕시브
에트리콕시브
세계의 요천추 신경근 통증 관리 시장 : 오피오이드 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
트라마돌
옥시코돈
모르핀
히드로코돈
펜타닐
세계의 요천추 신경근 통증 관리 시장 : 항우울제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
아미트립틸린
노르트립틸린
듀록세틴
데스벤라팍신
벤라팍신
세계의 요천추 신경근 통증 관리 시장 : 항경련제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
가바펜틴
프레가 발린
카르바마제핀
라모트리긴
토피라마트
세계의 요천추 신경근 통증 관리 시장 : 스테로이드 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
덱사메타손
메틸프레드니솔론
프레드니손
트리암시놀론
하이드로코르티손
제7장 지역 및 국가별 분석
세계의 요천추 신경근 통증 관리 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 요천추 신경근 통증 관리 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
요천추 신경근 통증 관리 시장 : 경쟁 구도
요천추 신경근 통증 관리 시장 : 기업 프로파일
Pfizer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Sanofi SA
Bristol-Myers Squibb
제31장 기타 주요 기업 및 혁신 기업
AstraZeneca plc
Novartis AG
GSK plc
Medtronic plc
Eli Lilly and Company
Amgen Inc
Koninklijke Philips NV
Stryker Corporation
Teva Pharmaceutical Industries Ltd
Boston Scientific Corporation
Dr Reddy's Laboratories Ltd
NuVasive Inc.
Nobel Biocare Holdings AG
Ultradent Products Inc.
Nevro Corp.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
요천추 신경근 통증 관리 시장(2029년) : 새로운 기회를 제공하는 국가
요천추 신경근 통증 관리 시장(2029년) : 새로운 기회를 제공하는 부문
요천추 신경근 통증 관리 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Lumbosacral radicular pain management involves a comprehensive strategy for diagnosing, treating, and alleviating pain caused by irritation or compression of the spinal nerve roots in the lumbosacral region (lower back and sacral area). This condition is often linked to issues such as herniated discs, spinal stenosis, or degenerative disc disease. Treatment focuses on reducing inflammation, relieving pressure on the affected nerves, and supporting functional recovery. The primary goal is to improve mobility, reduce pain, and enhance the patient's overall quality of life.
The key categories of medications used in managing lumbosacral radicular pain include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, antidepressants, anticonvulsants, and steroids. NSAIDs are commonly used as a first-line treatment to alleviate pain and inflammation by blocking the enzymes responsible for inflammation. Management may also involve various physical therapies, including manual therapy, exercise therapy, electrotherapy, thermal therapy, and hydrotherapy. These treatments are delivered through different routes, such as oral and topical administration, and are made available through multiple distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The lumbosacral radicular pain management market research report is one of a series of new reports from The Business Research Company that provides lumbosacral radicular pain management market statistics, including the lumbosacral radicular pain management industry global market size, regional shares, competitors with the lumbosacral radicular pain management market share, detailed lumbosacral radicular pain management market segments, market trends, opportunities, and any further data you may need to thrive in the lumbosacral radicular pain management industry. This lumbosacral radicular pain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The lumbosacral radicular pain management market size has grown strongly in recent years. It will grow from $0.85 billion in 2024 to $0.90 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the increasing prevalence of lumbar disc herniation, heightened awareness of spinal disorders, a growing elderly population, advancements in diagnostic imaging technologies, and the broader adoption of non-invasive pain management therapies.
The lumbosacral radicular pain management market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The anticipated growth in the forecast period can be attributed to innovations in minimally invasive surgical techniques, the rising adoption of biologic therapies, an increasing emphasis on personalized pain management, growing demand for outpatient pain clinics, and the integration of digital health and telemedicine into pain management practices. Key trends expected during this period include progress in minimally invasive spine surgeries, advancements in neurostimulation devices, the use of biologic therapies such as platelet-rich plasma, the application of AI-driven diagnostics and personalized treatment strategies, and the development of new non-opioid analgesics.
The increasing prevalence of back pain disorders is expected to drive the growth of the lumbosacral radicular pain management market in the coming years. Back pain disorders encompass various conditions affecting the spine, muscles, or nerves in the back, resulting in discomfort or pain. This rise is largely attributed to sedentary lifestyles that weaken back muscles, leading to poor posture and chronic pain. Lumbosacral radicular pain management focuses on alleviating nerve root irritation in the lower back, thereby reducing pain and inflammation, restoring mobility, and enhancing overall quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency, reported that in 2022, more than half (52%) of hospitalizations for back problems were due to back or spinal pain, with lower back pain accounting for the highest proportion at 27%, followed by neck pain at 6.2% and radiculopathy at 6.0%. Additionally, back problems had become the third leading contributor to the total health burden in 2023, representing 4.3% of the overall impact. As a result, the growing prevalence of back pain disorders is a key factor fueling the expansion of the lumbosacral radicular pain management market.
Leading companies in the lumbosacral radicular pain management market are concentrating on developing advanced therapies, such as investigational oral NaV1.8 pain signal inhibitors, to provide non-opioid options for long-lasting pain relief. These investigational drugs target the NaV1.8 sodium channel, a critical component in transmitting pain signals through sensory nerves. For example, in December 2024, Vertex Pharmaceuticals, a U.S.-based biotechnology company, released results from its Phase 2 clinical trial of suzetrigine for treating painful lumbosacral radiculopathy (LSR). The trial achieved its primary endpoint, demonstrating a statistically significant and clinically meaningful reduction in pain from baseline in patients receiving suzetrigine. The drug was generally well tolerated, with no serious adverse events reported. Vertex plans to address the high placebo response observed in the study in upcoming Phase 3 trials to better evaluate the drug's efficacy.
In October 2024, Stryker Corporation, a U.S.-based medical technology company, acquired Vertos Medical Inc. for an undisclosed amount. Through this acquisition, Stryker seeks to expand its interventional pain management portfolio, increase its footprint in ambulatory surgery centers, and enhance its capabilities in minimally invasive treatments for chronic lower back pain. Vertos Medical Inc. is a U.S.-based company specializing in interventional pain management solutions, particularly the minimally invasive mild(R) procedure for treating lumbar spinal stenosis.
Major players in the lumbosacral radicular pain management market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy's Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc.
North America was the largest region in the lumbosacral radicular pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lumbosacral radicular pain management report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the lumbosacral radicular pain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lumbosacral radicular pain management market consists of revenues earned by entities by providing services such as psychological therapy, surgical intervention, chiropractic care, and pharmacological management. The market value includes the value of related goods sold by the service provider or included within the service offering. The lumbosacral radicular pain management market includes sales of muscle relaxants, epidural steroid injections, and nerve blocks. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lumbosacral Radicular Pain Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lumbosacral radicular pain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lumbosacral radicular pain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lumbosacral radicular pain management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Lumbosacral Radicular Pain Management Market Trends And Strategies
4. Lumbosacral Radicular Pain Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Lumbosacral Radicular Pain Management Growth Analysis And Strategic Analysis Framework
5.1. Global Lumbosacral Radicular Pain Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lumbosacral Radicular Pain Management Market Growth Rate Analysis
5.4. Global Lumbosacral Radicular Pain Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lumbosacral Radicular Pain Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lumbosacral Radicular Pain Management Total Addressable Market (TAM)
6.1. Global Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Antidepressants
Anticonvulsants
Steroids
6.2. Global Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manual Therapy
Exercise Therapy
Electrotherapy
Thermal Therapy
Hydrotherapy
6.3. Global Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
6.4. Global Lumbosacral Radicular Pain Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ibuprofen
Naproxen
Diclofenac
Celecoxib
Etoricoxib
6.6. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Opioids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tramadol
Oxycodone
Morphine
Hydrocodone
Fentanyl
6.7. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Antidepressants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amitriptyline
Nortriptyline
Duloxetine
Desvenlafaxine
Venlafaxine
6.8. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Anticonvulsants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gabapentin
Pregabalin
Carbamazepine
Lamotrigine
Topiramate
6.9. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Steroids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dexamethasone
Methylprednisolone
Prednisone
Triamcinolone
Hydrocortisone
7. Lumbosacral Radicular Pain Management Market Regional And Country Analysis
7.1. Global Lumbosacral Radicular Pain Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lumbosacral Radicular Pain Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lumbosacral Radicular Pain Management Market
9.1. China Lumbosacral Radicular Pain Management Market Overview
9.2. China Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lumbosacral Radicular Pain Management Market
10.1. India Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lumbosacral Radicular Pain Management Market
11.1. Japan Lumbosacral Radicular Pain Management Market Overview
11.2. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lumbosacral Radicular Pain Management Market
12.1. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lumbosacral Radicular Pain Management Market
13.1. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lumbosacral Radicular Pain Management Market
14.1. South Korea Lumbosacral Radicular Pain Management Market Overview
14.2. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lumbosacral Radicular Pain Management Market
15.1. Western Europe Lumbosacral Radicular Pain Management Market Overview
15.2. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lumbosacral Radicular Pain Management Market
16.1. UK Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lumbosacral Radicular Pain Management Market
18.1. France Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lumbosacral Radicular Pain Management Market
21.1. Eastern Europe Lumbosacral Radicular Pain Management Market Overview
21.2. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lumbosacral Radicular Pain Management Market
22.1. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lumbosacral Radicular Pain Management Market
23.1. North America Lumbosacral Radicular Pain Management Market Overview
23.2. North America Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lumbosacral Radicular Pain Management Market
24.1. USA Lumbosacral Radicular Pain Management Market Overview
24.2. USA Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lumbosacral Radicular Pain Management Market
26.1. South America Lumbosacral Radicular Pain Management Market Overview
26.2. South America Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lumbosacral Radicular Pain Management Market
27.1. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lumbosacral Radicular Pain Management Market
28.1. Middle East Lumbosacral Radicular Pain Management Market Overview
28.2. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lumbosacral Radicular Pain Management Market
29.1. Africa Lumbosacral Radicular Pain Management Market Overview
29.2. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lumbosacral Radicular Pain Management Market Competitive Landscape And Company Profiles
